GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Eloxx Pharmaceuticals ELOX · USD

Health Care · US listing · 🇺🇸 United States

Compare

13.51

+8.60%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

11 analysts, 1 Nov 2026. The analysts' own views, not ours.

  • 4Strong buy
  • 6Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Nov 2026. Not our view.

Average target 40.50

Low
38.00
Average
40.50
Median
40.50
High
43.00

Forecasts

Analyst averages for the fiscal years ahead

FY2027
Revenue$173.8m
Revenue, highest$173.8m
Revenue, lowest$173.8m
Earnings per share-2.69
Earnings per share, highest-1.81
Earnings per share, lowest-3.57
Analysts1

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q1 2026
Forecast-0.70-6.40
Reported-0.66-0.88
Difference+6.3%+86.3%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 0.0% a year over 10 years. Return on equity 338.3%.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.